The Centers for Medicare & Medicaid Services (CMS) has released detailed payment amounts, performance targets, and reporting requirements for the Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) Model, applicable to care periods beginning July 5 through December 31, 2027.
The healthcare group purchasing industry continues to provide critical market savings to hospitals, nursing homes, and medical practices throughout the United States – even as a panoply of issues place undue strain on healthcare supply chains – according to the 20th Annual Report of the Healthcare Group Purchasing Industry Initiative (HGPII).
On February 3, President Trump signed a $1.2 trillion funding package into law just hours after the House passed the Senate’s amended version of the FY2026 appropriations package, H.R. 7148, ending a brief partial government shutdown that began in the early hours of January 31.
Massachusetts proposed amendments to the regulations that govern skilled nursing facilities (SNFs). Here is what operators, real property owners, and investors need to know as they acquire facilities, change managers, and navigate licensure renewals in Massachusetts.
The longevity ecosystem sits at the crossroads of health care, life sciences, consumer wellness, artificial intelligence (AI), and other emerging technologies.
In recent months, three federal courts have refused to enforce expansive U.S. Department of Justice administrative subpoenas issued to providers of gender-affirming care, concluding that the subpoenas were issued for an improper purpose or exceeded the government’s statutory authority.
Life Sciences Industry Group Co-Leader Stephanie Trunk was quoted on the US Department of Health and Human Services’ Office of Inspector General (OIG) guidance that pharmaceutical manufacturers would face a “low risk” of violating federal anti-kickback laws when selling directly to patients through the planned TrumpRx site.
On January 27, the US Department of Health and Human Services Office of Inspector General (OIG) issued a Special Advisory Bulletin providing significant guidance for pharmaceutical manufacturers offering prescription drugs through direct-to-consumer (DTC) programs to patients enrolled in federal health care programs.
On behalf of a coalition of the nation’s leading organizations dedicated to the care, health, education, well-being, and welfare of children and families, ArentFox Schiff, filed an amicus brief in the US Court of Appeals for the Ninth Circuit in support of the plaintiffs.
ArentFox Schiff is pleased to announce the launch of its Longevity & Healthspan Industry Group, a cross-sector initiative supporting the rapidly expanding ecosystem of companies advancing anti-aging innovation, wellness, and preventive health.
False Claims Act Investigations Partners Hillary Stemple (Health Care) and Nadia Patel (Litigation) will host a Continuing Education webinar on recent trends in health care fraud enforcement for the Health Care Compliance Association on January 27, 2026.
Pascal Naples was quoted on a recent “unfavorable” opinion published by the Office of Inspector General (OIG) for the US Department of Health and Human Services that sign-on bonuses for caregivers providing in-home care for Medicaid recipients would fall under the anti-kickback statute.
On January 6, the US Food and Drug Administration (FDA) released two significant updates potentially important for companies operating in the consumer health technology space.
The enforcement landscape entering 2026 points to sustained False Claims Act activity across traditional health care fraud, AI-enabled misconduct, civil rights–based claims, customs and tariff fraud, and expanding theories of investor liability.
The telehealth industry is entering a new phase of scrutiny marked by intensified enforcement actions across civil and criminal fronts that reflect a coordinated, whole-of-government approach.
Last month, a federal court in Maine halted the US Department of Health and Human Services (HHS) Health Resources and Services Administration’s (HRSA) 340B Rebate Model Pilot Program in its tracks — a mere four days before it was to go into effect.